Press Releases Sedana Medical AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:42 2024-05-10 am EDT			5-day change	1st Jan Change
20.95 ^SEK	-2.10%		-7.71%	-9.54%

Apr. 25	Transcript : Sedana Medical AB, Q1 2024 Earnings Call, Apr 25, 2024
Apr. 25	Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Sedana Medical Q1 - Set to beat conservative sales target	Apr. 26	AQ
Sedana Medical AB's Interim report January-March 2024	Apr. 25	AQ
Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US	Apr. 25	AQ
Notice of Annual General Meeting in Sedana Medical	Apr. 22	AQ
Sedana Medical publishes its Annual Report for 2023	Apr. 15	AQ
Invitation to presentation of Sedana Medical's interim report for the first quarter 2024	Apr. 05	AQ
Sedana Medical Q4 - Likely to beat conservative 2024 sales target	Feb. 16	AQ
Sedana Medical AB's Year-end report 2023	Feb. 15	AQ
Invitation to presentation of Sedana Medical's fourth quarter and year-end report for 2023	Jan. 25	AQ
Sedana Medical files submission for paediatric indication	Dec. 20	AQ
Sedana Medical secures data exclusivity and market protection for Sedaconda[®] (isoflurane) until 2031	Nov. 22	AQ
Key results of Sedana Medical's paediatric study IsoCOMFORT published	Nov. 16	AQ
Sedana Medical Q3 - Accelerated geographical expansion up next	23-10-30	AQ
Sedana Medical AB's Interim report January-September 2023	23-10-26	AQ
Sedana Medical's Nomination Committee established	23-10-24	AQ
The SESAR investigator-initiated trial completes patient enrollment	23-10-23	AQ
Sedana Medical receives market approval in the UK	23-10-10	AQ
Invitation to presentation of Sedana Medical's interim report for the third quarter 2023	23-10-05	AQ
Sedana Medical receives US patent for Sedaconda ACD-S	23-09-29	AQ
Sedana Medical's CEO and CFO acquire shares in the company	23-09-26	AQ

No results for this search